title: [Aclarubicin in metastatic thyroid cancer: initial clinical experience].
authors.forename: W
authors.initials: W
authors.lastname: Langsteger
authors.forename: P
authors.initials: P
authors.lastname: Lind
authors.forename: O
authors.initials: O
authors.lastname: Eber
authors.forename: P
authors.initials: P
authors.lastname: Költringer
authors.forename: G
authors.initials: G
authors.lastname: Klima
mesh_terms: D015250:Aclarubicin; D000230:Adenocarcinoma / Q000188:drug therapy; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009279:Naphthacenes / Q000627:therapeutic use; D013964:Thyroid Neoplasms / Q000188:drug therapy*
chemical_list: D000903:Antibiotics, Antineoplastic; D009279:Naphthacenes; D015250:Aclarubicin
vernacular_title: Aclarubicin bei metastasierendem Schilddrüsenkarzinom: Erste klinische Erfahrungen.